ArticleCancers2019

Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells.

Haneen Amawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.